1
|
Antunes FTT, Angelo SG, Dallegrave E, Picada JN, Marroni NP, Schemitt E, Ferraz AG, Gomez MV, de Souza AH. Recombinant peptide derived from the venom the Phoneutria nigriventer spider relieves nociception by nerve deafferentation. Neuropeptides 2020; 79:101980. [PMID: 31711615 DOI: 10.1016/j.npep.2019.101980] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Revised: 10/10/2019] [Accepted: 10/13/2019] [Indexed: 12/17/2022]
Abstract
The avulsion of nerve roots of the brachial plexus that is commonly seen in motorcycle accidents is a type of neuropathy due to deafferentation. This type of pain is clinically challenging since therapeutical protocols fail or have severe side effects. Thus, it is proposed to evaluate the antinociceptive activity of the recombinant CTK 01512-2 peptide that is derived from the venom of the Phoneutria nigriventer spider, as a future new therapeutical option. The neuropathic pain was surgically induced by avulsion of the upper brachial plexus trunk in groups of male Wistar rats and after 17 days, they were treated intrathecally with morphine, ziconotide, and CTK 01512-2. Behavioral tests were performed to evaluate mechanical and thermal hyperalgesia, cold allodynia, the functional activity of the front paw, and exploratory locomotion after the treatments. The peripheral blood samples were collected 6 h after the treatments and a comet assay was performed. The spinal cord was removed for the lipoperoxidation dosing of the membranes. The cerebrospinal fluid was analyzed for the dosage of glutamate. The recombinant peptide showed an antinociceptive effect when compared to the other drugs, without affecting the locomotor activity of the animals. Mechanical and thermal hyperalgesia, as well as cold allodynia, were reduced in the first hours of treatment. The levels of glutamate and the damage by membrane lipoperoxidation were shown to be improved, and genotoxicity was not demonstrated. In a scenario of therapeutical failures in the treatment of this type of pain, CTK 01512-2 was shown as a new effective alternative protocol. However, further testing is required to determine pharmacokinetics.
Collapse
Affiliation(s)
- Flavia Tasmin Techera Antunes
- Program of Postgraduation in Cellular and Molecular Biology Applied to Health (PPGBioSaúde), Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | | | - Eliane Dallegrave
- Department of Pharmacoscience, University Federal of Science of Health of Porto Alegre (UFCSPA), Rio Grande do Sul, Brazil
| | - Jaqueline Nascimento Picada
- Laboratory of Genetic Toxicology, PPGBioSaúde and PPGGTA, Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | - Norma Possa Marroni
- Laboratory of Oxidative Stress and Antioxidants, PPGBioSaúde and PPGGTA, Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | - Elizangela Schemitt
- Laboratory of Oxidative Stress and Antioxidants, PPGBioSaúde and PPGGTA, Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | - Alice Gomes Ferraz
- Laboratory of Pharmacology, Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | - Marcus Vinicius Gomez
- Nucleus of Postgraduation, Institute of Teaching and Research of Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
| | - Alessandra Hubner de Souza
- Program of Postgraduation in Cellular and Molecular Biology Applied to Health (PPGBioSaúde), Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil.
| |
Collapse
|
2
|
de Souza AH, da Rosa LG, Uliano MR, da Silva Prado L, Ferraz AG, Conter LU, Grivicich I, Dallegrave E, Gomez MV, Picada JN. Evaluation of DNA damage in spinal cord and mutagenic effect of a Phα1β recombinant toxin with analgesic properties from the Phoneutria nigriventer spider. Basic Clin Pharmacol Toxicol 2018; 124:615-620. [PMID: 30449066 DOI: 10.1111/bcpt.13171] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Accepted: 11/06/2018] [Indexed: 12/12/2022]
Abstract
Phα1β peptide isolated from the venom of the Phoneutria nigriventer spider has shown higher analgesic action in pre-clinical studies than ω-conotoxin MVIIA peptide used to treat severe chronic pain. In view of the great potential for the development of a new Phα1β-based drug, a Phα1β recombinant form (CTK 01512-2) has been studied for efficacy and safety. The aim of this study was to evaluate cytotoxic, genotoxic and mutagenic effects of a Phα1β recombinant form and compare it with native Phα1β and ω-conotoxin MVIIA. Cytotoxicity was evaluated using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) colourimetric assay in L929 mouse fibroblast cells (0.5-10.0 μmol/L). Genotoxic and mutagenic activities were analysed using the alkaline comet assay in peripheral blood and spinal cord, and the micronucleus test in bone marrow from Wistar rats treated by intrathecal injection of CTK 01512-2 (200, 500 and 1000 pmol/site), native Phα1β (500 pmol/site) and ω-conotoxin MVIIA (200 pmol/site). CTK 01512-2 decreased the cell viability of the L929, showing IC50 of 3.3 ± 0.1 µmol/L, while the Phα1β and ω-conotoxin MVIIA did not show cytotoxicity (IC50 > 5.0 µmol/L). Native and recombinant Phα1β forms induced DNA damage in the spinal cord, but not in peripheral blood. CTK 01512-2 at 1000 pmol/site increased the micronucleus frequency suggesting mutagenic effects. In conclusion, the recombinant form has cytotoxic, genotoxic and mutagenic effects, evidenced in doses five times above the therapeutic dose.
Collapse
Affiliation(s)
| | - Luiza Gabriela da Rosa
- Laboratory of Pharmacology and Toxicology, Lutheran University of Brazil (ULBRA), Canoas, Brazil
| | - Michel Rossi Uliano
- Laboratory of Pharmacology and Toxicology, Lutheran University of Brazil (ULBRA), Canoas, Brazil.,Laboratory of Toxicological Genetics, Lutheran University of Brazil (ULBRA), Canoas, Brazil
| | - Lismare da Silva Prado
- Laboratory of Toxicological Genetics, Lutheran University of Brazil (ULBRA), Canoas, Brazil
| | - Alice Gomes Ferraz
- Laboratory of Pharmacology and Toxicology, Lutheran University of Brazil (ULBRA), Canoas, Brazil.,Laboratory of Toxicological Genetics, Lutheran University of Brazil (ULBRA), Canoas, Brazil
| | | | - Ivana Grivicich
- Laboratory of Cancer Biology, Lutheran University of Brazil (ULBRA), Canoas, Brazil
| | - Eliane Dallegrave
- Department of Pharmacosciences. Federal, University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil
| | - Marcus Vinícius Gomez
- Laboratory of Toxins, Institute of Education and Research Santa Casa Belo Horizonte, Belo Horizonte, Brazil
| | | |
Collapse
|